Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Abbvie inc.    crawled date : 2022 - 05 - 11    save search

Genmab Announces Financial Results for the First Quarter of 2022
Published: 2022-05-11 (Crawled : 15:20) - globenewswire.com
GNMSF | News | $289.67 1.8% 3.83% 5.3K twitter stocktwits trandingview |
Health Technology
| | O: -0.51% H: 2.39% C: -0.57%
NVSEF | News | $95.11 5.4% 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: 0.81% H: 0.0% C: -0.09%
NVS | News | $95.12 0.81% 5.43% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 1.2% C: -0.85%
JNJ | News | $149.12 0.82% 0.3% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.87% H: 0.0% C: 0.0%
ABBV | News | $167.89 0.89% 0.51% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 0.0% C: 0.0%
HALO M | $38.71 0.18% 0.16% 530K twitter stocktwits trandingview |
Health Technology
| | O: 0.94% H: 2.18% C: 0.05%
GMAB | News | $28.97 0.94% 0.93% 450K twitter stocktwits trandingview |
Health Technology
| | O: -0.54% H: 0.96% C: -4.44%


Upadacitinib (RINVOQ®) Achieved Clinical Remission and Endoscopic Response at One Year in Phase 3 Maintenance Study in Patients with Crohn's Disease
Published: 2022-05-11 (Crawled : 13:00) - biospace.com/
ABBV | News | $167.89 0.89% 0.51% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 0.0% C: 0.0%

rinvoq disease response one phase 3
Dementia and Movement Disorder Treatment Market: 45% of Growth to Originate from North America | By Drug Class and Geography - Forecast and Analysis 2022-2026
Published: 2022-05-11 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $95.11 5.4% 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: 0.81% H: 0.0% C: -0.09%
NVS | News | $95.12 0.81% 5.43% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 1.2% C: -0.85%
GSK | News | $40.59 2.11% 0.57% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.65% H: 1.14% C: -1.14%
BHC | $8.45 -2.76% 0.0% 2.4M twitter stocktwits trandingview |
Health Technology
| | O: 15.69% H: 13.62% C: 9.04%
ABBV | News | $167.89 0.89% 0.51% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 0.0% C: 0.0%
BIIB | $194.11 -0.14% -0.15% 930K twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 3.04% C: -0.63%

america treatment dementia drug growth
Gainers vs Losers
74% 26%

Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M twitter stocktwits trandingview |

AGBA | $2.5 100.0% 56.6% 200M twitter stocktwits trandingview |
Finance

MLEC | $2.47 76.43% 42.62% 78M twitter stocktwits trandingview |
n/a

NUWE | $0.334 29.96% 40.99% 2.5M twitter stocktwits trandingview |
Manufacturing

EDBL | News | $6.26 66.49% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.86 46.25% 32.8% 180K twitter stocktwits trandingview |

VIVK | $1.43 33.65% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.7M twitter stocktwits trandingview |

SDIG A | $3.64 35.32% 26.0% 990K twitter stocktwits trandingview |

PROK | $2.72 33.33% 24.58% 2.6M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.